Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Monitor Science Corp. — Predicate Candidate Screening
6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
66 daysmedian FDA review time
76 days90th percentile
6clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K790580 | RIA KIT, PROSTATIC ACID | Monitor Science Corp. | 1979-05-25 | 59 | 0 |
| K780950 | BIO-MONITOR TOBRAMYCIN | Monitor Science Corp. | 1978-08-14 | 66 | 0 |
| K780949 | BIO-MONITOR AMIKACIN | Monitor Science Corp. | 1978-08-14 | 66 | 0 |
| K780951 | BIO-MONITOR GENTAMICIN | Monitor Science Corp. | 1978-08-14 | 66 | 0 |
| K772038 | KANAMYCIN RIA | Monitor Science Corp. | 1978-01-12 | 76 | 0 |
| K772039 | BETA-HCG RIA | Monitor Science Corp. | 1977-11-23 | 26 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda